| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/04/2003 | WO2003044187A3 Emulsion compositions |
| 09/04/2003 | WO2003036267A3 Filtration system and method for obtaining a cytology layer |
| 09/04/2003 | WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2003030129A3 Labelled articles and uses thereof |
| 09/04/2003 | WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/04/2003 | WO2003027635A3 Detection of fusarium species infecting corn using the polymerase chain reaction |
| 09/04/2003 | WO2003027225A3 Regulation of human steroid 5-alpha reductase |
| 09/04/2003 | WO2003018765A3 A high throughput method for identification of sequence tags |
| 09/04/2003 | WO2003014366A3 Rna amplification system using plant components in animal cells |
| 09/04/2003 | WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 09/04/2003 | WO2003005890A3 Affinity biosensor for monitoring of biological process |
| 09/04/2003 | WO2003001212A3 A method for diagnosing a person having multiple sclerosis |
| 09/04/2003 | WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 09/04/2003 | WO2002101017A3 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor |
| 09/04/2003 | WO2002099130A3 Virus detection using degenerate pcr primers |
| 09/04/2003 | WO2002097435A3 Assay method for platelet-activating factor |
| 09/04/2003 | WO2002097395A3 P-cadherin as a target for anti-cancer therapy |
| 09/04/2003 | WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins |
| 09/04/2003 | WO2002081749A3 Detection of aberrant dna methylation as marker for human cancer |
| 09/04/2003 | WO2002081656A3 Enhanced diagnostic potential of prostate-specific antigen expressing cells |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/04/2003 | WO2002070703A3 Cell visual characteristic-modifying sequences |
| 09/04/2003 | WO2002066952A3 Mass defect labeling for the determination of oligomer sequences |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002063049A3 Methods for determining a nucleotide at a specific location within a nucleic acid molecule |
| 09/04/2003 | WO2002061124A3 Analysis of methylation patterns in genomic dna using bisulfite treatment and fluorescence polarisation assay techniques |
| 09/04/2003 | WO2002061079A3 Biligands |
| 09/04/2003 | WO2002061041A3 Solubility reporter gene constructs |
| 09/04/2003 | WO2002057493A3 Methods for determining organisms |
| 09/04/2003 | WO2002055742A3 Rapid method for screening compounds for in vivo activity |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 09/04/2003 | WO2002048396A3 Sensor for detecting macromolecular biopolymers |
| 09/04/2003 | WO2002046472A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 09/04/2003 | WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 09/04/2003 | WO2002046353A3 Self-spreading microbiological culture device |
| 09/04/2003 | WO2002040995A3 Method for estimating metabolic function of xenobiotic and induction thereof |
| 09/04/2003 | WO2002036807A3 Compositions and methods relating to breast specific genes and proteins |
| 09/04/2003 | WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 09/04/2003 | WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 09/04/2003 | WO2002032928A3 Haplotypes of the hrh1 gene |
| 09/04/2003 | WO2002031484A8 Methods for characterizing molecular interactions using affinity capture tandem mass spectrometry |
| 09/04/2003 | WO2002031166A3 Artificial transcriptional factors and methods of use |
| 09/04/2003 | WO2002029103A3 Gene expression profiles in liver cancer |
| 09/04/2003 | WO2002029094A3 Method of selection, by two-dimensional separation, of nucleic acids that bind to a target with high affinity |
| 09/04/2003 | WO2002022870A3 Method for the characterization and/or identification of genomes |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002018643A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 09/04/2003 | WO2002016935A9 Screening method for discovering auxiliary agents promoting endocytosis |
| 09/04/2003 | WO2002010741A3 Regional intestinal permeability model |
| 09/04/2003 | WO2002010458A3 Method of performing subtractive hybridization |
| 09/04/2003 | WO2002008456A3 Method for identifying metastatic tumor cells |
| 09/04/2003 | WO2002002808A3 Method and nucleic acids for the analysis of astrocytomas |
| 09/04/2003 | WO2002000932A3 Diagnosis of known genetic parameters within the mhc |
| 09/04/2003 | WO2001098765A9 Multianalyte molecular analysis |
| 09/04/2003 | WO2001096605A3 Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
| 09/04/2003 | WO2001094629A3 Cancer gene determination and therapeutic screening using signature gene sets |
| 09/04/2003 | WO2001090416A3 Methods and compositions for preparation of a polynucleotide array |
| 09/04/2003 | WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 09/04/2003 | WO2001081622A3 Diagnosis of diseases associated with dna repair |
| 09/04/2003 | WO2001076451A3 Diagnosis of diseases associated with metabolism |
| 09/04/2003 | WO2001066799A3 Real time quantitative pcr with intercalating dye for single and multiplex target dna |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | WO2001055720A3 A system for developing assays for personalized medicine |
| 09/04/2003 | US20030167538 Genetic engineered plants; corn, wheat, rice |
| 09/04/2003 | US20030167536 Plant adpglucose pyroghophatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants |
| 09/04/2003 | US20030167527 Transgenic plant; genetic engineering |
| 09/04/2003 | US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests |
| 09/04/2003 | US20030167521 Genetic engineered insecticide |
| 09/04/2003 | US20030167512 Method of determining the presence of a trait in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in a positive orientation |
| 09/04/2003 | US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences |
| 09/04/2003 | US20030167495 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes |
| 09/04/2003 | US20030167487 Homologous recombination; stem cells; drug screening; platelets |
| 09/04/2003 | US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London |
| 09/04/2003 | US20030167480 Diagnosis, therapy of cancer using antibodies; detcting, calibration binding |
| 09/04/2003 | US20030167135 Non-linear modelling of biological activity of chemical compounds |
| 09/04/2003 | US20030167134 Determination radiation; biological warfare; culture product; polymerase chain reactions |
| 09/04/2003 | US20030167133 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
| 09/04/2003 | US20030166917 Purification by chromatography, ion exchanging, analyzing |
| 09/04/2003 | US20030166915 Retrovirus from the HIV group and its use |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166908 Seafood protein; measuring water absorption of fish bladder |
| 09/04/2003 | US20030166903 Genes associated with vascular disease |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166897 Diagnosis, therapy cancer; transgenic animal |
| 09/04/2003 | US20030166896 Polynucleotide containing phosphoramidite group |
| 09/04/2003 | US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders |
| 09/04/2003 | US20030166891 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 09/04/2003 | US20030166862 Purified mammalian CTLA-8 antigens and related reagents |
| 09/04/2003 | US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 09/04/2003 | US20030166847 Novel human leptin receptor gene-related protein |
| 09/04/2003 | US20030166832 Methods and compositions for impairing multiplication of HIV-1 |
| 09/04/2003 | US20030166599 Uses of tgap7 for the modulation of leucocyte activation |
| 09/04/2003 | US20030166587 Compounds and methods for modulating activation of NF-kB |
| 09/04/2003 | US20030166568 Organic compounds |
| 09/04/2003 | US20030166562 Treatment for asthma or allergies |
| 09/04/2003 | US20030166554 Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |